Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.
about
Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Simvastatin Reduces Cancerogen ...... sphate and Mevalonate Pathway.
@en
Simvastatin Reduces Cancerogen ...... sphate and Mevalonate Pathway.
@nl
type
label
Simvastatin Reduces Cancerogen ...... sphate and Mevalonate Pathway.
@en
Simvastatin Reduces Cancerogen ...... sphate and Mevalonate Pathway.
@nl
prefLabel
Simvastatin Reduces Cancerogen ...... sphate and Mevalonate Pathway.
@en
Simvastatin Reduces Cancerogen ...... sphate and Mevalonate Pathway.
@nl
P2093
P2860
P1433
P1476
Simvastatin Reduces Cancerogen ...... sphate and Mevalonate Pathway.
@en
P2093
Ingo Marzi
Katrin Jurida
Mathias Woschek
Niels Kneip
P2860
P304
P356
10.1080/01635581.2016.1152383
P50
P577
2016-04-04T00:00:00Z